Page last updated: 2024-11-02

pioglitazone and Aberrant Tissue

pioglitazone has been researched along with Aberrant Tissue in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shea, MK1
Nicklas, BJ1
Marsh, AP1
Houston, DK1
Miller, GD1
Isom, S1
Miller, ME1
Carr, JJ1
Lyles, MF1
Harris, TB1
Kritchevsky, SB1

Trials

1 trial available for pioglitazone and Aberrant Tissue

ArticleYear
The effect of pioglitazone and resistance training on body composition in older men and women undergoing hypocaloric weight loss.
    Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:8

    Topics: Abdominal Fat; Absorptiometry, Photon; Aged; Body Composition; Body Mass Index; Choristoma; Diet, Re

2011